281 related articles for article (PubMed ID: 26510488)
1. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.
Ota K; Dambaeva S; Han AR; Beaman K; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2014 Feb; 29(2):208-19. PubMed ID: 24277747
[TBL] [Abstract][Full Text] [Related]
4. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
Yang X; Meng T
J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
[TBL] [Abstract][Full Text] [Related]
6. Determination of clinical cellular immune markers in women with recurrent pregnancy loss.
Lee SK; Na BJ; Kim JY; Hur SE; Lee M; Gilman-Sachs A; Kwak-Kim J
Am J Reprod Immunol; 2013 Nov; 70(5):398-411. PubMed ID: 23656517
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.
Stricker RB; Steinleitner A; Bookoff CN; Weckstein LN; Winger EE
Fertil Steril; 2000 Mar; 73(3):536-40. PubMed ID: 10689009
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
10. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
[TBL] [Abstract][Full Text] [Related]
11. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion.
Winger EE; Reed JL
Am J Reprod Immunol; 2008 Jul; 60(1):8-16. PubMed ID: 18422811
[TBL] [Abstract][Full Text] [Related]
12. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions.
Kwak JY; Kwak FM; Ainbinder SW; Ruiz AM; Beer AE
Am J Reprod Immunol; 1996 Apr; 35(4):363-9. PubMed ID: 8739455
[TBL] [Abstract][Full Text] [Related]
13. Does immunotherapy for treatment of reproductive failure enhance live births?
Coulam CB; Acacio B
Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial.
Ahmadi M; Aghdam SA; Nouri M; Babaloo Z; Farzadi L; Ghasemzadeh A; Hamdi K; Movassaghpour AA; Jadidi-Niaragh F; Afkham A; Motallebnezhad M; Eghbal-Fard S; Dolati S; Younesi V; Yousefi M
Immunol Lett; 2017 Dec; 192():12-19. PubMed ID: 29030251
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
16. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
Stricker RB; Winger EE
Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion.
Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
Am J Reprod Immunol; 1996 Apr; 35(4):370-5. PubMed ID: 8739456
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.
Jafarzadeh S; Ahmadi M; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Kamrani A; Behrad B; Roshangar L; Jadidi-Niaragh F; Yousefi B; Mehdipour M; Farzadi L; Yousefi M
J Cell Biochem; 2019 Apr; 120(4):5424-5434. PubMed ID: 30326143
[TBL] [Abstract][Full Text] [Related]
19. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy as an effective treatment of recurrent spontaneous abortion--own experience].
Jerzak M; Rechberger T; Baranowski W; Semczuk M
Ginekol Pol; 2003 Oct; 74(10):1107-11. PubMed ID: 14669403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
